6.69
-0.06 (-0.89%)
| Previous Close | 6.75 |
| Open | 6.75 |
| Volume | 63,154 |
| Avg. Volume (3M) | 241,788 |
| Market Cap | 1,295,210,752 |
| Price / Sales | 45.55 |
| Price / Book | 30.82 |
| 52 Weeks Range | |
| Earnings Date | 4 Sep 2025 - 8 Sep 2025 |
| Profit Margin | -67.73% |
| Operating Margin (TTM) | -115.65% |
| Diluted EPS (TTM) | -0.080 |
| Quarterly Revenue Growth (YOY) | 40.80% |
| Total Debt/Equity (MRQ) | 25.78% |
| Current Ratio (MRQ) | 3.17 |
| Operating Cash Flow (TTM) | -12.93 M |
| Levered Free Cash Flow (TTM) | -14.06 M |
| Return on Assets (TTM) | -19.93% |
| Return on Equity (TTM) | -55.43% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Bearish |
| Medical Devices (Global) | Bearish | Bearish | |
| Stock | SS Innovations International In | - | - |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | 0.0 |
| Price Volatility | 2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 1.5 |
| Average | 0.50 |
|
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Growth |
| % Held by Insiders | 83.38% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| SRIVASTAVA SUDHIR | 6.25 | 6.25 | 4,000 | 25,000 |
| Aggregate Net Quantity | 4,000 | |||
| Aggregate Net Value ($) | 25,000 | |||
| Aggregate Avg. Buy ($) | 6.25 | |||
| Aggregate Avg. Sell ($) | 6.25 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SRIVASTAVA SUDHIR | Officer | 11 Aug 2025 | Acquired (+) | 20,000 | 6.25 | 125,000 |
| SRIVASTAVA SUDHIR | Officer | 11 Aug 2025 | Disposed (-) | 16,000 | 6.25 | 100,000 |
| Date | Type | Details |
|---|---|---|
| 07 Aug 2025 | Announcement | SS Innovations Reports Second Quarter 2025 Financial Results |
| 22 Jul 2025 | Announcement | SS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac Telesurgery |
| 15 Jul 2025 | Announcement | SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System |
| 10 Jul 2025 | Announcement | SS Innovations Announces Completion of World’s First Robotic Telesurgery for Weight Loss with the Company’s SSi Mantra 3 Surgical Robotic System |
| 16 Jun 2025 | Announcement | SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company’s SSi Mantra 3 Surgical Robotic System |
| 02 Jun 2025 | Announcement | SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |